Details for New Drug Application (NDA): 076061
✉ Email this page to a colleague
NDA 076061 describes PERGOLIDE MESYLATE, which is a drug marketed by Ivax Sub Teva Pharms and Strides Pharma and is included in two NDAs. Additional details are available on the PERGOLIDE MESYLATE profile page.
The generic ingredient in PERGOLIDE MESYLATE is pergolide mesylate. There are four drug master file entries for this compound. Additional details are available on the pergolide mesylate profile page.
The generic ingredient in PERGOLIDE MESYLATE is pergolide mesylate. There are four drug master file entries for this compound. Additional details are available on the pergolide mesylate profile page.
Summary for 076061
| Tradename: | PERGOLIDE MESYLATE |
| Applicant: | Strides Pharma |
| Ingredient: | pergolide mesylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076061
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 0.05MG BASE | ||||
| Approval Date: | Nov 27, 2002 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 0.25MG BASE | ||||
| Approval Date: | Nov 27, 2002 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Nov 27, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
